Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis.
Horai Y, Koga T, Fujikawa K, Takatani A, Nishino A, Nakashima Y, Suzuki T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Ida H, Kakugawa T, Sakamoto N, Ishimatsu Y, Mukae H, Hamaguchi Y, Fujimoto M, Kuwana M, Origuchi T, Kohno S, Kawakami A. Horai Y, et al. Among authors: nakashima y. Mod Rheumatol. 2015 Jan;25(1):85-9. doi: 10.3109/14397595.2014.900843. Epub 2014 Apr 9. Mod Rheumatol. 2015. PMID: 24716595
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri SY, Okada A, Koga T, Yamasaki S, Nakamura H, Origuchi T, Aramaki T, Nakashima M, Fujikawa K, Tsukada T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Among authors: nakashima m, nakashima y. Mod Rheumatol. 2012 Apr;22(2):195-201. doi: 10.1007/s10165-011-0511-y. Epub 2011 Sep 6. Mod Rheumatol. 2012. PMID: 21898075 Clinical Trial.
Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration.
Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri SY, Iwamoto N, Okada A, Koga T, Yamasaki S, Nakamura H, Origuchi T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Among authors: nakashima y. Mod Rheumatol. 2012 Jun;22(3):346-52. doi: 10.1007/s10165-011-0522-8. Epub 2011 Sep 30. Mod Rheumatol. 2012. PMID: 21960457
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.
Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, Suzuki T, Nakashima Y, Tamai M, Arima K, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Ishimatsu Y, Mukae H, Kuwana M, Kohno S, Eguchi K, Aoyagi K, Kawakami A. Koga T, et al. Among authors: nakashima y. Rheumatology (Oxford). 2012 Jul;51(7):1278-84. doi: 10.1093/rheumatology/ker518. Epub 2012 Feb 29. Rheumatology (Oxford). 2012. PMID: 22378718 Free article.
Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach.
Kita J, Tamai M, Arima K, Kawashiri SY, Horai Y, Iwamoto N, Okada A, Koga T, Nakashima Y, Suzuki T, Yamasaki S, Nakamura H, Origuchi T, Ida H, Aoyagi K, Uetani M, Eguchi K, Kawakami A. Kita J, et al. Among authors: nakashima y. Mod Rheumatol. 2013 Mar;23(2):254-9. doi: 10.1007/s10165-012-0646-5. Epub 2012 Jun 6. Mod Rheumatol. 2013. PMID: 22669596
Takayasu arteritis developing during treatment of ulcerative colitis with infliximab.
Horai Y, Satoru O, Lapalme-Remis S, Sumiyoshi R, Nakashima Y, Suzuki T, Okada A, Kawashiri SY, Ichinose K, Tamai M, Yamasaki S, Nakamura H, Takeshima F, Origuchi T, Kawakami A. Horai Y, et al. Among authors: nakashima y. Mod Rheumatol. 2013 May;23(3):572-6. doi: 10.1007/s10165-012-0684-z. Epub 2012 Jun 21. Mod Rheumatol. 2013. PMID: 22718488
Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naïve early-stage rheumatoid arthritis patients.
Kawashiri SY, Suzuki T, Nakashima Y, Horai Y, Okada A, Iwamoto N, Ichinose K, Tamai M, Arima K, Nakamura H, Origuchi T, Uetani M, Aoyagi K, Kawakami A. Kawashiri SY, et al. Among authors: nakashima y. Mod Rheumatol. 2015;25(6):948-53. doi: 10.3109/14397595.2013.844394. Epub 2013 Nov 13. Mod Rheumatol. 2015. PMID: 24252054
A case of cutaneous polyarteritis nodosa with elevated serum interleukin-6 levels complicated by leg arterial stenosis and destructive arthropathy of the left ankle.
Horai Y, Tokuyama A, Sumiyoshi R, Nakashima Y, Suzuki T, Okada A, Kawashiri SY, Ichinose K, Izumi Y, Miyashita T, Tamai M, Yamasaki S, Nakamura H, Hayashi T, Origuchi T, Kawakami A. Horai Y, et al. Among authors: nakashima y. Mod Rheumatol. 2014 Jan;24(1):206-11. doi: 10.3109/14397595.2013.852840. Mod Rheumatol. 2014. PMID: 24261780
Presence of ultrasound subclinical synovitis and increment of serum vascular endothelial growth factor in a patient with rheumatoid arthritis achieved in sustained clinical remission by treatment with adalimumab and methotrexate.
Kawashiri SY, Arima K, Suzuki T, Nakashima Y, Horai Y, Okada A, Tamai M, Nakamura H, Kawakami A. Kawashiri SY, et al. Among authors: nakashima y. Mod Rheumatol. 2014 Jul;24(4):681-4. doi: 10.3109/14397595.2013.874736. Epub 2014 Feb 18. Mod Rheumatol. 2014. PMID: 24533548
2,461 results